May 11 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 12.14 12.06 12.80
(+0.7 pct) (-2.1 pct) (+5.4 pct)
Operating 727 mln 589 mln 610 mln
(+23.4 pct) (-16.1 pct)
Recurring 708 mln 608 mln 600 mln
(+16.3 pct) (-15.3 pct)
Net
Net 760 mln 576 mln 470 mln
(+31.9 pct) (-38.2 pct)
EPS 201.07 yen 152.47 yen 124.29 yen
Ann Div 40.00 yen 40.00 yen 40.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 40.00 yen 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T